|View printer-friendly version|
|June 17, 2001 11:31 a.m.|
|Teva Announces Approval of Lovastatin Tablets|
Jerusalem, Israel, June 17, 2001 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has awarded final approval for Lovastatin Tablets 10, 20 and 40 mg. The company anticipates launch over the next few weeks.